(Q37651104)
Statements
Metabotropic glutamate receptor 5 negative modulation in phase I clinical trial: potential impact of circadian rhythm on the neuropsychiatric adverse reactions-do hallucinations matter? (English)
Corine Baljé-Volkers
4 March 2014
1 reference
1 reference
1 reference